As in mouse AAA lesions, immunofluorescent double staining revealed increased numbers of METTL14-positive SMCs and β-catenin-positive SMCs, but decreased SMC SOST expression in human AAA lesions compared with those in normal human aortas (Fig. 7B-D). The gene discussed is METTL14; the disease is triple-A syndrome.